EU Reserves 300mn Doses Of Potential COVID-19 Vaccine

Donald Trump

The technology involved was originally used by Sanofi to create an influenza vaccine, and will now be supplemented by GSK's established pandemic adjuvant technology. If the trials prove effective, the companies plan to request United States regulatory approval for the vaccine in the first half of 2021.

Under the deal announced, Sanofi and its partner, the British pharmaceutical company GlaxoSmithKline, will receive federal funding to pay for clinical trials as well as for manufacturing the vaccine.

"The US government will provide up to $2.1 billion, more than half of which is to support further development of the vaccine, including clinical trials", the companies said in a statement.

"We're committed to making any vaccine that is developed through this collaboration affordable and through mechanisms that offer fair access for all people", GlaxoSmithKline CEO Emma Walmsley said in April.

The companies have agreed to carry out fill-finish manufacturing in the that vaccine doses are packaged and ready to ship immediately if clinical trials are successful and FDA authorizes use.

If approved, the 100 million doses of this vaccine will be available to Americans at no cost, according to the announcement by the Department of Health and Human Services. We are expecting more vaccines from the companies soon.

It further states, "the high-income countries could act as an inclusive global buyers' group, thus accelerating the development of safe and effective vaccines and maximise access to them for all who need it across the world". The companies expect to produce 1 billion doses of the vaccine per year globally.

The companies said the doses would be manufactured in European countries including France, Belgium, Germany and Italy.

The Sanofi-GSK deal is for 100 million doses, at two per person, and gives the government an option to purchase an additional 500 million doses at an unspecified price.

"It is a huge conflict of interest for the White House's new vaccine czar to own $10 million of stock in a company receiving government funding to develop a Covid-19 vaccine", Warren tweeted.

Earlier in May, Sanofi was under fire for remarks saying that once its vaccine under research goes to market, the US had the right to pre-order because it has invested in it.

The World Health Organization is among global organizations participating in the ACT accelerator effort, along with the Bill & Melinda Gates Foundation; the Coalition for Epidemic Preparedness Innovations (CEPI); the Foundation for Innovative New Diagnostics (FIND); Gavi, The Vaccine Alliance; The Global Fund; Unitaid;, Wellcome; The World Bank; and the World-Bank-supported Global Financing Facility.



Other news